TG THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2021 to Q2 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Tg Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q2 2024.
- Tg Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 159M shares, a 12.7% increase year-over-year.
- Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 149M shares, a 9.67% increase from 2022.
- Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 135M shares, a 2.41% increase from 2021.
- Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 132M shares, a 14.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)